Table 3.
Dependent variables | β | B (Per-SD increase) | 95% CI | P | R2 |
---|---|---|---|---|---|
Log VAI (model 1) | 0.113 | 0.094 | 0.061–0.127 | < 0.001 | 0.014 |
Log VAI (model 2) | 0.073 | 0.062 | 0.032–0.092 | < 0.001 | 0.278 |
Log VAI (model 3) | 0.070 | 0.060 | 0.030–0.090 | < 0.001 | 0.280 |
Log CVAI (model 1) | 0.141 | 0.062 | 0.046–0.078 | < 0.001 | 0.169 |
Log CVAI (model 2) | 0.112 | 0.050 | 0.034–0.066 | < 0.001 | 0.283 |
Log CVAI (model 3) | 0.101 | 0.045 | 0.029–0.061 | < 0.001 | 0.293 |
Log LAP (model 1) | 0.122 | 0.130 | 0.088–0.172 | < 0.001 | 0.022 |
Log LAP (model 2) | 0.101 | 0.110 | 0.070–0.149 | < 0.001 | 0.248 |
Log LAP (model 3) | 0.094 | 0.103 | 0.063–0.142 | < 0.001 | 0.251 |
Model 1 adjusted for age and smoking.
Model 2 adjusted for age, smoking, HOMA-IR, hypertension and dyslipidemia.
Model 3 adjusted for age, smoking, HOMA-IR, hypertension, dyslipidemia, total testosterone (proportion above vs. below detection limit) and estradiol (proportion above vs. below detection limit).